Literature DB >> 21309258

Endometrioid carcinoma of the endometrium: pathologic and molecular features.

Ainara Azueta1, Sonia Gatius, Xavier Matias-Guiu.   

Abstract

Endometrioid carcinoma of the endometrium is the most common type of endometrial carcinoma. The microscopic appearance of the tumor resembles that of the proliferative endometrium, with a variable degree of glandular complexity and cellular pleomorphism. Several subtypes have been described, including the presence of squamous differentiation, villoglandular pattern, secretory features and ciliated cells. Recently recognized subtypes are the tumors that arise in the setting of hereditary nonpolyposis colon cancer syndrome, tumors with small nonvillous papillae, presence of microglandular pattern, sertoliform features, and dedifferentiated carcinomas. The main differential diagnosis includes endocervical adenocarcinoma, atypical polypoid adenomyoma, malignant mixed Müllerian tumors, and metastatic tumors to the endometrium. The main prognostic factors are stage, histologic grade, myometrial, cervical and vascular invasion. There are several pathologic features that should be recognized to avoid underestimation of these prognostic factors, such as presence of MELF pattern of myometrial invasion, and invasion of the cervical stroma with a deceptive pattern of spread. Six different molecular features are frequent in this type of tumor, including microsatellite instability, and mutations in PTEN, k-RAS, PIK3CA, FGFR2 and CTNNB1.

Entities:  

Mesh:

Year:  2010        PMID: 21309258     DOI: 10.1053/j.semdp.2010.09.001

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  10 in total

1.  Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy.

Authors:  Deanna M Janzen; Miguel A Rosales; Daniel Y Paik; Daniel S Lee; Daniel A Smith; Owen N Witte; M Luisa Iruela-Arispe; Sanaz Memarzadeh
Journal:  Cancer Res       Date:  2013-06-06       Impact factor: 12.701

2.  Stromal cells of endometrial carcinoma promotes proliferation of epithelial cells through the HGF/c-Met/Akt signaling pathway.

Authors:  Min Li; Xiaoyan Xin; Tingting Wu; Teng Hua; Hongbin Wang; Hongbo Wang
Journal:  Tumour Biol       Date:  2015-03-18

3.  Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.

Authors:  Sònia Gatius; Mariona Jove; Cristina Megino-Luque; Manel Albertí-Valls; Andree Yeramian; Nuria Bonifaci; Miquel Piñol; Maria Santacana; Irene Pradas; David Llobet-Navas; Reinald Pamplona; Xavier Matías-Guiu; Núria Eritja
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

4.  miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer.

Authors:  Bi-Lan Li; Cong Lu; Wen Lu; Ting-ting Yang; Junjie Qu; Xiayu Hong; Xiao-ping Wan
Journal:  Med Oncol       Date:  2013-02-08       Impact factor: 3.064

5.  Overexpression of the matrix metalloproteinase 11 gene is a potential biomarker for type 1 endometrial cancer.

Authors:  Gabriela Sofía Gómez-Macías; María Lourdes Garza-Rodríguez; Raquel Garza-Guajardo; Daniela Monsiváis-Ovalle; Jesús Ancer-Rodríguez; Hugo Alberto Barrera-Saldaña; Oralia Barboza-Quintana
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

6.  Enolase-1 is a therapeutic target in endometrial carcinoma.

Authors:  Mengyang Zhao; Weiyi Fang; Yan Wang; Suiqun Guo; Luyun Shu; Lijing Wang; YiYu Chen; Qiaofen Fu; Yan Liu; Shengni Hua; Yue Fan; Yiyi Liu; Xiaojie Deng; Rongcheng Luo; Zhong Mei; Qinping Jiang; Zhen Liu
Journal:  Oncotarget       Date:  2015-06-20

7.  CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer.

Authors:  Bi-Lan Li; Wen Lu; Cong Lu; Jun-Jie Qu; Ting-Ting Yang; Qin Yan; Xiao-Ping Wan
Journal:  Cancer Cell Int       Date:  2013-05-16       Impact factor: 5.722

8.  Hospital-based study of epithelial malignancies of endometrial cancer frequency in lahore, pakistan, and common diagnostic pitfalls.

Authors:  Imrana Tanvir; Sabiha Riaz; Afshan Hussain; Riffat Mehboob; M Usman Shams; Haseeb Ahmad Khan
Journal:  Patholog Res Int       Date:  2014-01-06

9.  Elevated MiR-222-3p promotes proliferation and invasion of endometrial carcinoma via targeting ERα.

Authors:  Binya Liu; Qi Che; Haifeng Qiu; Wei Bao; Xiaoyue Chen; Wen Lu; Bilan Li; Xiaoping Wan
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

10.  Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells.

Authors:  Xin Nie; Lingling Gao; Mingjun Zheng; Caixia Wang; Shuang Wang; Xiao Li; Yue Qi; Liancheng Zhu; Juanjuan Liu; Bei Lin
Journal:  J Cancer       Date:  2021-07-31       Impact factor: 4.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.